Clinical Trials Browser

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

NCT04561362 2025-11-14

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Phase 1/2 Active not recruiting

329 enrolled

BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Renal Insufficiency, Triple Negative Breast Neoplasms

NCT07124403 2025-09-17

DESIR

Not yet recruiting

742 enrolled

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Renal Insufficiency

NCT07117409 2025-09-11

RI-NIVO

Terminated

81 enrolled

Genitourinary

Carcinoma, Carcinoma, Renal Cell, Renal Insufficiency

NCT05992363 2025-07-24

TSTENT

Phase NA Recruiting

106 enrolled

Bites and Stings, Hydronephrosis, Neoplasms, Ureteral Obstruction, Renal Insufficiency

NCT01047735 2025-07-11

TRIABETES

Phase NA Active not recruiting

69 enrolled

Other

Behavior, Blindness, Body Weight, Cardiovascular Diseases, Death, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Disease, Hypertension, Inflammation, Insulin Resistance, Liver Diseases, Motor Activity, Myocardial Infarction, Neoplasms, Obesity, Obesity, Morbid, Weight Loss, Atherosclerosis, Renal Insufficiency, Non-alcoholic Fatty Liver Disease

NCT07053462 2025-07-08

CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Phase 1/2 Recruiting

90 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Renal Insufficiency

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Phase 2 Recruiting

18 enrolled

Gynecologic

Uterine Cervical Neoplasms, Renal Insufficiency

NCT04398745 2025-05-23

DREAMM12

Phase 1 Active not recruiting

36 enrolled

GenitourinaryPlasma cell

Kidney Failure, Chronic, Multiple Myeloma, Renal Insufficiency

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Completed

1,149 enrolled

Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis